Capreomycin sulfate
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281643This classification denotes an antitubercular agent and aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9H8D3J7V21. European Medicines Agency schedules Capreomycin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01029MIG. Capreomycin sulfate generally arises in the molecular formula C25H46N14O12S. The term 'capreomycin sulfate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule capreomycin sulfate under HS 29419000 and SITC 54139. Capreomycin sulfate bears US NLM identifiers UMLS ID C0006920 and NCI Concept Code C73797. SMILES: As of Q4 2014, CAPREOMYCIN SULFATE remains US FDA's Preferred Term for this commodity.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.